Recorded Chinese product: 藻酸双酯钠片藻酸双酯钠片
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 江西新赣江药业有限公司Chinese legal name: 江西新赣江药业有限公司
主要成分Active Ingredients
- 藻酸双酯钠Zaosuan Shuangzhi Na
药物知识说明
藻酸双酯钠是一种在国家药监局注册认定的药品。该药品含有藻酸双酯钠-93faac35等成分。
该药品关联的活性成分包括：藻酸双酯钠Zaosuan Shuangzhi Na。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：江西新赣江药业有限公司Chinese legal name: 江西新赣江药业有限公司。
您可以探索含有相同成分的其他药品：藻酸双酯钠-93faac35成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 藻酸双酯钠片) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 藻酸双酯钠Zaosuan Shuangzhi Na.
Manufacturers recorded for this product: 江西新赣江药业有限公司Chinese legal name: 江西新赣江药业有限公司.
Explore other medicines containing the same ingredient: 藻酸双酯钠 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 藻酸双酯钠片Recorded Chinese product: 藻酸双酯钠片
- 剂型Dosage form: 片剂Tablets
- 规格Specification: 50mg50 mg
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 江西新赣江药业有限公司Chinese legal name: 江西新赣江药业有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H36021474
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H36021474
Manufacturer
Chinese legal name: 江西新赣江药业有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
Protect from light and keep tightly closed.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H36021474
生产企业
江西新赣江药业有限公司(国产)
适应症
本品主要用于缺血性脑血管病如脑血栓、脑栓塞、短暂性脑缺血发作及心血管疾病如高血压、高脂蛋白血症、冠心病、心绞痛等疾病的防治。也可用于治疗弥漫性血管内凝血、慢性肾小球肾炎及出血热等。
用法用量
口服:一次50～100mg，一日2～3次。
不良反应
口服时不良反应很少见，偶有个别患者出现恶心、头晕、皮疹等，停药后症状消失。
禁忌
有出血病史、血友病、脑溢血及严重肝、肾功能不全者禁用本品。
注意事项
凡有下列病症者慎用本品:|1.低血压低血容量者|2.血小板减少症|3.非高粘滞血症非血小板聚集亢进|4.过敏性体质
贮藏
遮光，密闭保存。
规格
50mg
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.